A detailed history of Manufacturers Life Insurance Company, The transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 134,087 shares of CRNX stock, worth $7.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
134,087
Previous 131,063 2.31%
Holding current value
$7.23 Million
Previous $5.87 Million 16.68%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$43.83 - $54.98 $132,541 - $166,259
3,024 Added 2.31%
134,087 $6.85 Million
Q2 2024

Aug 14, 2024

BUY
$42.12 - $51.91 $985,523 - $1.21 Million
23,398 Added 21.73%
131,063 $5.87 Million
Q1 2024

May 14, 2024

BUY
$34.76 - $46.81 $928,057 - $1.25 Million
26,699 Added 32.98%
107,665 $5.04 Million
Q4 2023

Feb 13, 2024

BUY
$25.62 - $37.07 $437,666 - $633,266
17,083 Added 26.74%
80,966 $2.88 Million
Q3 2023

Nov 15, 2023

BUY
$15.97 - $30.59 $203,186 - $389,196
12,723 Added 24.87%
63,883 $1.9 Million
Q2 2023

Aug 11, 2023

BUY
$15.73 - $23.6 $483,618 - $725,582
30,745 Added 150.6%
51,160 $921,000
Q4 2022

Aug 11, 2023

BUY
$15.49 - $19.05 $340 - $419
22 Added 0.11%
20,415 $373,000
Q4 2022

Feb 13, 2023

BUY
$15.49 - $19.05 $340 - $419
22 Added 0.11%
20,415 $373,000
Q3 2022

Aug 11, 2023

SELL
$18.11 - $22.37 $8,095 - $9,999
-447 Reduced 2.14%
20,393 $400,000
Q3 2022

Nov 03, 2022

SELL
$18.11 - $22.37 $8,095 - $9,999
-447 Reduced 2.14%
20,393 $401,000
Q2 2022

Aug 11, 2023

BUY
$16.49 - $27.64 $47,491 - $79,603
2,880 Added 16.04%
20,840 $388,000
Q2 2022

Aug 15, 2022

BUY
$16.49 - $27.64 $47,491 - $79,603
2,880 Added 16.04%
20,840 $389,000
Q1 2022

Aug 11, 2023

SELL
$17.15 - $28.31 $42,103 - $69,501
-2,455 Reduced 12.03%
17,960 $394,000
Q1 2022

May 20, 2022

SELL
$17.15 - $28.31 $70,143 - $115,787
-4,090 Reduced 18.55%
17,960 $394,000
Q4 2021

Feb 16, 2022

BUY
$19.35 - $28.41 $35,778 - $52,530
1,849 Added 9.15%
22,050 $626,000
Q3 2021

Nov 12, 2021

SELL
$16.88 - $25.23 $26,991 - $40,342
-1,599 Reduced 7.33%
20,201 $425,000
Q2 2021

Aug 12, 2021

BUY
$15.9 - $21.15 $71,247 - $94,773
4,481 Added 25.87%
21,800 $411,000
Q1 2021

May 03, 2021

BUY
$13.3 - $17.55 $1,010 - $1,333
76 Added 0.44%
17,319 $265,000
Q4 2020

Feb 12, 2021

BUY
$12.08 - $17.46 $10,026 - $14,491
830 Added 5.06%
17,243 $243,000
Q2 2020

Aug 10, 2020

BUY
$13.04 - $23.23 $214,025 - $381,273
16,413 New
16,413 $293,000

Others Institutions Holding CRNX

About Crinetics Pharmaceuticals, Inc.


  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.9B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.